GSK (GSK)
38.65
0.08 (0.21%)
At close: Mar 25, 2025, 3:59 PM
38.55
-0.26%
After-hours: Mar 25, 2025, 07:59 PM EDT
0.21% (1D)
| Bid | 38.54 |
| Market Cap | 78.78B |
| Revenue (ttm) | 15.7B |
| Net Income (ttm) | 1.29B |
| EPS (ttm) | 1.62 |
| PE Ratio (ttm) | 23.86 |
| Forward PE | 8.66 |
| Analyst | Hold |
| Ask | 38.56 |
| Volume | 5,002,237 |
| Avg. Volume (20D) | 4,825,811 |
| Open | 39.28 |
| Previous Close | 38.57 |
| Day's Range | 38.52 - 39.31 |
| 52-Week Range | 31.72 - 45.93 |
| Beta | 0.29 |
About GSK
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines ...
Industry Drug Manufacturers - General
Sector Healthcare
IPO Date Mar 28, 1980
Employees 68,629
Stock Exchange NYSE
Ticker Symbol GSK
Website https://www.gsk.com
Analyst Forecast
According to 4 analyst ratings, the average rating for GSK stock is "Hold." The 12-month stock price forecast is $47, which is an increase of 21.60% from the latest price.
Stock Forecasts1 month ago
+8.21%
GSK shares are trading higher after the company re...
Unlock content with
Pro Subscription
1 month ago
+3.59%
GSK shares are trading higher after the company announced the European Medicines Agency will review Shingrix for regulatory application.
